Disease

Unapproved stem-cell therapies marketed to people with long COVID Evgeniia Medvedeva/iStock CIDRAP

New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.

...

A new Covid variant has become dominant amid slow uptake of the updated shots The HV.1 variant took over this week as the dominant variant in the U.S., but just around 3.5 % of the population has received an updated Covid shot thus far. NBC News

...

Why is COVID-19 more severe in some people? Researchers use genetics, data science to find out Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of ... Tyler Irving Medical Xpress

Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of Toronto and partner hospitals, may hold the answers to this question—and many more.

...